FDA Inspection 1231238 — Imprimis NJOF, LLC
The FDA completed an inspection of Imprimis NJOF, LLC on Apr 3, 2024 in Ledgewood, NJ. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Apr 3, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ledgewood, NJ (United States)